RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment

Experimental and Molecular Pathology
Pei-Hang LeeWan-Ting Huang

Abstract

The World Health Organization, in a 2016 revision, introduced recurrent genetic abnormalities for classifying mature T- and NK-cell neoplasms. However, the role of genetic analyses from lymph node aspiration cytology is still not elucidated. We hypothesize that the use of genetic analyses may increase the accuracy of diagnosis from cytological preparations. Fifty-seven formalin-fixed paraffin-embedded (FFPE) samples were collected for next-generation sequencing (NGS) targeting potential driver mutations including TET2, DMN3TA, IDH2, RHOA, STAT3, and STAT5B. Competitive allele-specific TaqMan polymerase chain reaction (cast-PCR) was performed to validate the mutation status by using FFPE and preoperative fine needle aspiration cytology (FNAC) samples. Among these six candidate genes, only IDH2 and RHOA mutations were significantly more frequent in nodal subtypes, angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) (P = .002 and <0.001, respectively). All genes exhibited different mutation patterns except RHOA with a hotspot mutation involving the Gly17 residue. The RHOA G17V mutation was found in 15 (75%) of 20 AITL and two (22%) of nine PTCL, NOS. Cast-PCR using FFPE sam...Continue Reading

References

Aug 26, 2010·Cytopathology : Official Journal of the British Society for Clinical Cytology·S SchmidB Bode
Jan 14, 2011·American Journal of Clinical Pathology·Erica C SavageChris S Jensen
Jan 6, 2012·The New England Journal of Medicine·Lucile CouronnéOlivier A Bernard
May 18, 2012·The New England Journal of Medicine·Hanna L M KoskelaSatu Mustjoki
Dec 19, 2013·Blood·Oreofe OdejideDavid M Weinstock
Jan 15, 2014·Nature Genetics·Mamiko Sakata-YanagimotoShigeru Chiba
May 13, 2014·Nature Genetics·Miwako KakiuchiShumpei Ishikawa
Jul 22, 2014·Genes, Chromosomes & Cancer·Marius RohdeUNKNOWN NHL-BFM Study Group
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jan 15, 2015·Nature Communications·Can KüçükWing C Chan
Apr 1, 2015·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Tetsuo UshikuMasashi Fukayama
Oct 6, 2015·Nature Genetics·Keisuke KataokaSeishi Ogawa
Oct 16, 2015·PLoS Pathogens·Francesco AbateRaul Rabadan
Nov 18, 2015·Blood·Yasunobu NagataSeishi Ogawa
Nov 18, 2015·The American Journal of Surgical Pathology·Sarah L OndrejkaEric D Hsi
Feb 6, 2016·Blood·Shumpei Ishikawa
Aug 26, 2016·Acta Cytologica·Anna Lucia PelusoPio Zeppa
Dec 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·François LemonnierTak W Mak
Jul 12, 2017·The Journal of Clinical Investigation·Shengbing ZangYun Huang
Feb 5, 2019·American Journal of Clinical Pathology·Natasha D NovikovDavid M Dorfman

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease & TET2

Cardiovascular diseases are the number one cause of deaths globally. Tet methylcytosine dioxygenase 2 (TET2)-mediated hematopoiesis has been implicated in accelerating heart failure. Here is the latest research on cardiovascular diseases and TET2.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.